Reference health
Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
69/69 checkable references clean · checked 2026-07-23
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 69 checked references that resolve
resolves10.1016/j.npep.2015.06.008
Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
resolves10.1038/s41598-018-21468-w
The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer’s Disease
resolves10.1016/j.jalz.2016.02.010
Neuroinflammation in Alzheimer's disease: Current evidence and future directions
resolves10.1016/j.jep.2011.08.030
Effects of a Chinese traditional formula Kai Xin San (KXS) on chronic fatigue syndrome mice induced by forced wheel running
resolves10.1016/j.jep.2018.06.007
Active components, derived from Kai-xin-san, a herbal formula, increase the expressions of neurotrophic factor NGF and BDNF on mouse astrocyte primary cultures via cAMP-dependent signaling pathway
resolves10.1186/s13024-018-0299-8
Advances in developing novel therapeutic strategies for Alzheimer’s disease
resolves10.1371/journal.pone.0015939
TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
resolves10.1038/mp.2016.214
Caspase-3-dependent cleavage of Akt modulates tau phosphorylation via GSK3β kinase: implications for Alzheimer’s disease
resolves10.1016/j.neulet.2004.01.016
Candidate gene association studies of the α4 (CHRNA4) and β2 (CHRNB2) neuronal nicotinic acetylcholine receptor subunit genes in Alzheimer's disease
resolves10.1016/j.jtcme.2016.12.003
Alzheimer Disease: Clues from traditional and complementary medicine
resolves10.2174/1567205013666160930110551
Targeting Tumor Necrosis Factor Alpha for Alzheimer’s Disease
resolves10.15252/emmm.201809717
A promising, novel, and unique BACE1 inhibitor emerges in the quest to prevent Alzheimer's disease
resolves10.1016/j.patbio.2014.08.002
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease
resolves10.1016/j.jep.2016.11.034
Network pharmacology-based study on the mechanism of action for herbal medicines in Alzheimer treatment
resolves10.1021/acs.jcim.7b00216
Quantitative and Systems Pharmacology. 1.<i>In Silico</i>Prediction of Drug–Target Interactions of Natural Products Enables New Targeted Cancer Therapy
resolves10.1016/j.ejmech.2018.10.020
Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease
resolves10.1016/j.jchromb.2018.06.032
High-throughput lipidomics characterize key lipid molecules as potential therapeutic targets of Kaixinsan protects against Alzheimer's disease in APP/PS1 transgenic mice
resolves10.1016/j.arr.2018.09.003
Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation
resolves10.1093/brain/awy132
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
resolves10.3233/JAD-170974
Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer’s Disease
resolves10.1016/j.arr.2009.10.001
Anti-aging herbal medicine—How and why can they be used in aging-associated neurodegenerative diseases?
resolves10.1038/nprot.2008.211
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
resolves10.1016/j.jalz.2017.12.006
The cost of Alzheimer's disease in China and re‐estimation of costs worldwide
resolves10.1016/j.bioorg.2017.09.004
Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer’s disease: A review
resolves10.1016/j.ejmech.2017.07.070
Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents
resolves10.1038/s41598-018-25381-0
Ameliorative potential of desalted Salicornia europaea L. extract in multifaceted Alzheimer’s-like scopolamine-induced amnesic mice model
resolves10.2174/1570159X16666180828100002
Current Progress on Peroxisome Proliferator-activated Receptor Gamma Agonist as an Emerging Therapeutic Approach for the Treatment of Alzheimer's Disease: An Update
resolves10.1186/s12906-015-0758-5
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine
resolves10.4049/jimmunol.1100620
Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer’s Disease Model
resolves10.1002/ptr.5764
Cognitive Ameliorating Effect of<i>Acanthopanax koreanum</i>Against Scopolamine-Induced Memory Impairment in Mice
resolves10.1021/ci500004h
AlzPlatform: An Alzheimer’s Disease Domain-Specific Chemogenomics Knowledgebase for Polypharmacology and Target Identification Research
resolves10.1016/j.jep.2016.10.002
Kai Xin San aqueous extract improves Aβ 1-40 -induced cognitive deficits on adaptive behavior learning by enhancing memory-related molecules expression in the hippocampus
resolves10.1093/hmg/dds128
Mitochondria-targeted catalase reduces abnormal APP processing, amyloid production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension
resolves10.1007/s11481-011-9287-2
Tumor Necrosis Factor-alpha and the Roles it Plays in Homeostatic and Degenerative Processes Within the Central Nervous System
resolves10.1002/med.21622
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
resolves10.1007/s11481-018-9824-3
Melatonin Rescue Oxidative Stress-Mediated Neuroinflammation/ Neurodegeneration and Memory Impairment in Scopolamine-Induced Amnesia Mice Model
resolves10.1016/j.clinbiochem.2019.04.001
Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease
resolves10.15252/embj.2019102345
Tau deletion reduces plaque‐associated BACE1 accumulation and decelerates plaque formation in a mouse model of Alzheimer's disease
resolves10.1093/nar/gkw943
DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants
resolves10.1016/j.bbadis.2011.10.011
Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeutics
resolves10.1186/1758-2946-6-13
TCMSP: a database of systems pharmacology for drug discovery from herbal medicines
resolves10.1126/scisignal.aao6765
Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β
resolves10.3390/biom6010006
Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies
resolves10.1111/j.1471-4159.2007.05127.x
Interleukin‐1β up‐regulates TACE to enhance α‐cleavage of APP in neurons: resulting decrease in Aβ production
resolves10.4103/1673-5374.205107
Neuroprotective mechanism of Kai Xin San: upregulation of hippocampal insulin-degrading enzyme protein expression and acceleration of amyloid-beta degradation
resolves10.1111/bph.13629
<i>In silico</i> prediction of chemical mechanism of action via an improved network‐based inference method
resolves10.1093/nar/gks1100
TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis
resolves10.2353/ajpath.2007.060378
Interferon-γ and Tumor Necrosis Factor-α Regulate Amyloid-β Plaque Deposition and β-Secretase Expression in Swedish Mutant APP Transgenic Mice
resolves10.1016/j.jsbmb.2014.07.001
Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders
resolves10.1038/s41598-017-03039-7
TCM-Mesh: The database and analytical system for network pharmacology analysis for TCM preparations
resolves10.1002/jcp.27709
GRK5 influences the phosphorylation of tau via GSK3β and contributes to Alzheimer's disease
resolves10.1016/j.jep.2013.11.007
A network-based analysis of the types of coronary artery disease from traditional Chinese medicine perspective: Potential for therapeutics and drug discovery
The 1 reference without a DOI — listed, not checked
no DOI — not checkedAlzheimer Disease
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.3389/fphar.2020.00381"><img src="https://citestamp.com/citestamped/10.3389/fphar.2020.00381/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.3389/fphar.2020.00381)